Article History
Received: 17 August 2017
Accepted: 12 October 2017
First Online: 23 October 2017
Compliance with ethical standards
:
: Philip Dunn and Deb Webb declare that they have no conflict of interest. Thomas Olenginski serves as a consultant to Amgen, currently working on a medication mining project with Amgen, and serves on Amgen Speaker’s Bureau.